231 Front Street, Lahaina, HI 96761 [email protected] 808.123.4567

Tag: 娱乐地图JMD

The Oxford BioDynamics share price is up 30% today. Here’s what I’d do now

first_img “This Stock Could Be Like Buying Amazon in 1997” Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Our 6 ‘Best Buys Now’ Shares Simply click below to discover how you can take advantage of this. The Oxford BioDynamics share price is up 30% today. Here’s what I’d do now I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Enter Your Email Addresscenter_img AIM-listed Oxford BioDynamics (LSE: OBD) is a stock in demand today. The Oxford BioDynamics share price has jumped 30% as I write. I am cautious before buying shares whose prices show that sharp a rise in one go. This is especially true for small-capitalisation companies (it has a market cap of £64m). The risks from investing in small caps can be higher, since they are often relatively new companies with limited track records, so I think it is essential to look at the company carefully. 5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Why did the Oxford BioDynamics share price rise?The Oxford BioDynamics share price rose on the launch of its Covid-19 severity test in the US. The test is useful in predicting the immune response to Sars-Cov-2, which is one of the coronavirus variants. It is distinct from available Covid-19 tests that can only detect infection if it exists or has existed in the past in the system. It uses its proprietary EpiSwitch services for this, which study epigenetic biomarkers. Epigenetics tells us how genes work in response to changes in the environment and lifestyle. Through its services, the company is able to assist pharmaceutical companies developing more cost effective and personalised treatment plans. A growing biomarkers marketIt estimates that the value of the global biomarkers market to be at $24bn and growing at a compounded annual growth rate (CAGR) of 14%. This sounds promising. It has also been generating revenues for a while now, indicating some success in tapping into the market. Disappointing financialsThe last two years have seen a decline in revenues, though. Even if we ignore 2020’s performance, considering that the pandemic set business back pretty much across the board, that still does leave us with its weakening 2019 performance.As is often the case in companies where significant product and market development is still ongoing, it is loss-making. I am not sure how long it will take to turn around. I normally like to buy profitable stocks and, if not, their revenue growth should then be substantial. That is not the case here.Volatile share price trendsMoreover, the latest share price increase might not be sustained either. The Oxford BioDynamics share price has a history of volatility. Its share price has also seen a broad decline over the past four years. If I have a two-to-three year investing horizon, it is a risky investment from that perspective. The upshot for the Oxford BioDynamics share priceStill, its launch in the US is an important development, when coronavirus variants could be the next big threat on the horizon. Considering that the pandemic is still around, the timing of the treatment could make Oxford BioDynamics a more important player in the biomarkers market than before.Like in the case of other emerging industries’ stocks, however, I would invest only what I can afford to lose. And even then, I would wait for a more opportune time to buy when its price has declined from its current levels.  Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! Image source: Getty Images Manika Premsingh | Tuesday, 23rd March, 2021 | More on: OBD See all posts by Manika Premsinghlast_img read more